A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a "killer peptide" that can eliminate therapy-resistant cells.

Tumor relapse is a common problem following cancer treatment, because primary tumor cells often contain therapy-resistance cancer cells that continue to proliferate after the therapy-sensitive cells have been eliminated.

[From the NIH Website]

Additional Guidance on ‘Full-Time Training’ for Ruth L. Kirschstein National Research Service Awards


Notice Number: NOT-OD-17-095
Key Dates
Release Date: July 24, 2017

Related Announcements
None

The total requests for new and amended subawards have steadily increased, per a recent update by Kim Carter, Executive Director, UK Office of Sponsored Projects Administration (OSPA).  With over 400 requests in FY17, administering subawards has quickly become a major part of research administration operations both at the College of Medicine (COM) and University-wide levels.  &nbs

Bailey, A. M., S. J. Legan, V. J. Meretsky, and G. E. Demas. "Effects of Exogenous Leptin on Seasonal Reproductive Responses to Interacting Environmental Cues in Female Siberian Hamsters." Gen Comp Endocrinol 250 (Sep 01 2017): 95-103. http://dx.doi.org/10.1016/j.ygcen.2017.06.004.

Sawada H, Rateri DL, Moorleghen JJ, Majesky MW, Daugherty A.

This time next year, the inaugural class of medical students at the new University of Kentucky College of Medicine-Bowling Green Campus will be attending their very first course, kicking off an exciting new opportunity for future Kentucky clinicians.